In a mouse model, PDT treatment with ML19B01 and ML19B02, two structurally related ruthenium photosensitizers, induced death of melanoma cells containing hallmarks of the ICD including HMGB1, which in turn activated antigen-presenting cells resulting in efficient phagocytosis by dendritic cells [57]. Here, HMGB1 is linked to melanoma.